Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1030
Gene Symbol: CDKN2B
CDKN2B
0.340 Biomarker disease BEFREE The CDK4 gene was amplified in two malignant gliomas without homozygous deletion of the MTS1/p16 and MTS2/p15 genes and one malignant glioma with an allelic loss of the genes. 7478535 1995
Entrez Id: 1030
Gene Symbol: CDKN2B
CDKN2B
0.340 Biomarker disease BEFREE Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas. 8526910 1995
Entrez Id: 1030
Gene Symbol: CDKN2B
CDKN2B
0.340 AlteredExpression disease BEFREE Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas. 10541865 1999
Entrez Id: 1030
Gene Symbol: CDKN2B
CDKN2B
0.340 GeneticVariation disease BEFREE Thirty-four to fifty-six percent of malignant gliomas harbor homozygous co-deletions of the INK4a(p16-p14ARF) and INK4b(p15) tumor suppressor genes. 11563632 2001
Entrez Id: 1030
Gene Symbol: CDKN2B
CDKN2B
0.340 Biomarker disease CTD_human Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. 19578366 2009
Entrez Id: 1030
Gene Symbol: CDKN2B
CDKN2B
0.340 Biomarker disease CTD_human Genome-wide association study identifies five susceptibility loci for glioma. 19578367 2009